Back to Screener

Energy

NewMed Energy - Limited Partnership(DKDRF)

Live Price

Offline

$5.52

+0.00% today

1Y Change

+18.46%

Window

Jun 26, 2025 โ†’ Jun 19, 2026

Market Cap
$7.27B
Revenue Growth
-17.4%
EPS Growth
-28.9%
Dividend Yield
3.7%

Coverage: 255 bars ยท Jun 26, 2025 โ†’ Jun 19, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

NewMed Energy - Limited Partnership (DKDRF) is a Energy stock with a market cap of $7.27B and listed on OTC. The stock last traded around $5.52 and up 18.5% across the available one-year price window (Jun 26, 2025 โ†’ Jun 19, 2026). Baseline metrics include revenue growth of -17.4%, EPS growth of -28.9%, a dividend yield of 3.7%. What stands out right now is revenue -17.4%, EPS -28.9%, free cash flow -34.2% with operating margin 52.8% and ROIC 10.3%. The dividend matters to the case here, with a current yield around 3.7%. Valuation sits in the middle of the pack at P/E 21.2 and price/sales 7.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DKDRF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Energy peers on this page.

Benchmark Edge

DKDRF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

DKDRF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

DKDRF Max Drawdown

-25.41%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for DKDRF and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

NewMed Energy - Limited Partnership (DKDRF)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$882.5M

-22.8% YoY

FY Net Income

$404.9M

-13.8% YoY

Free Cash Flow

$423.3M

+4.3% YoY

Revenue Growth

-17.4%

EPS Growth

-28.9%

Gross Margin

54.9%

Net Margin

35.0%

Income statement

USD

Annual
Metric20252024202320222021
Revenue938M1.1B935M1.1B883M
Gross Profit585M718M700M702M518M
Operating Income566M704M679M679M496M
EBITDA761M875M783M866M662M
Net Income371M525M434M470M405M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents108M51M29M22M220M
Total Assets4.0B4.0B3.8B3.9B3.9B
Total Liabilities2.1B2.2B2.3B2.7B2.9B
Shareholder Equity1.9B1.8B1.5B1.3B939M
Total Debt1.1B1.6B1.8B2.2B2.2B
Net Debt1.0B1.6B1.8B2.1B2.0B

Cash flow positioning

Latest Full Year

Operating Cash Flow

454M

-10.1% YoY

Capital Expenditures

30M

+69.3% YoY

Free Cash Flow

423M

+4.3% YoY

Key ratios

  • Gross Margin

    54.9%

  • Operating Margin

    52.8%

  • Net Margin

    35.0%

  • ROE

    18.2%

  • Debt / Equity

    0.59x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.